Oxagen Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Holding
- Established
- 1997-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.oxagen.co.uk
Clinical Trials
12
Active:5
Completed:7
Trial Phases
2 Phases
Phase 1:3
Phase 2:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 2
6 (66.7%)Phase 1
3 (33.3%)A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis
- First Posted Date
- 2011-10-07
- Last Posted Date
- 2011-10-07
- Lead Sponsor
- Oxagen Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT01448902
- Locations
- 🇦🇹
Vienna Challenge Chamber, Vienna, Austria
Safety and Efficacy Study of OC000459 Dosed Twice Daily for 28 Days in Asthmatic Subjects
- First Posted Date
- 2010-01-28
- Last Posted Date
- 2010-01-28
- Lead Sponsor
- Oxagen Ltd
- Target Recruit Count
- 132
- Registration Number
- NCT01057927
- Locations
- 🇷🇺
Sverdlovsk Regional Hospital #1, Ekaterinburg, Russian Federation
🇷🇺Research Institute of Pulmonology, Moscow, Russian Federation
🇷🇺Burdenko Main Military Hospital, Moscow, Russian Federation
Proof of Concept Study of OC000459 in Eosinophilic Esophagitis
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2012-01-05
- Lead Sponsor
- Oxagen Ltd
- Target Recruit Count
- 26
- Registration Number
- NCT01056783
- Locations
- 🇨🇭
Swiss EoE Research Group, Olten, Switzerland
OC000459 Bronchial Allergen Challenge
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2010-01-26
- Lead Sponsor
- Oxagen Ltd
- Target Recruit Count
- 20
- Registration Number
- NCT01056692
- Locations
- 🇬🇧
King's College London School of Medicine, London, United Kingdom
🇬🇧Medicines Evaluation Unit, Manchester, United Kingdom
Study to Evaluate the Potential for Interaction Between OC000459 and CYP 450 3A4
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2010-09-02
- Lead Sponsor
- Oxagen Ltd
- Target Recruit Count
- 20
- Registration Number
- NCT01056575
- Locations
- 🇬🇧
Simbec Research Ltd, Merthyr Tydfil, United Kingdom
- Prev
- 1
- 2
- Next
News
No news found